Researchers at City of Hope now understand why taking an investigational white button mushroom supplement shows promise in ...

In a study of US veterans, the authors say many would benefit from conservative management and active surveillance over ...

Overtreatment of older prostate cancer patients with a limited life expectancy has increased over the past two decades among ...

Prostate cancer treatment guidelines recommend against aggressive therapy for those with a life expectancy of less than 10 years.

Researchers at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United ...

Medically reviewed by Amelia MacIntyre, DO Approximately 1 in 8 people with a prostate are diagnosed with prostate cancer ...

Despite generic headwinds to Xarelto and challenges across different sectors of the conglomerate suggesting “twists and turns ...

Thumbs down for Roundup. Shocking research has revealed that more than a dozen chemicals used in popular weed killers like ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...

Prostate cancer is a growing problem in men, and advanced cases are rising for the first time in 20 years, which is why ...

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments that carry risks of side effects that can significantly reduce the quality ...

“The MMAI risk classifier is a more precise and accurate prognosticator of metastasis than NCCN risk groups,” Dr Tward’s team wrote. “This approach aims to prevent both overtreatment and ...